Investigating how FLASH radiation therapy protects healthy tissue during cancer treatment
Using experimentally-guided multi-scale modeling to determining the mechanism of FLASH tissue sparing
This study is looking at a new type of radiation therapy called FLASH, which gives quick bursts of high radiation to treat tumors while trying to protect healthy tissues, and it's aimed at helping patients by finding ways to reduce side effects from traditional treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10890754 on NIH RePORTER |
What this research studies
This research explores the effects of FLASH radiation therapy, which delivers high doses of radiation at rapid rates, on healthy tissues while effectively targeting tumors. By using animal models, the study aims to understand the mechanisms behind the tissue-sparing effects of FLASH therapy, which has shown promise in reducing damage to normal cells. The research combines experimental approaches with theoretical modeling to analyze how different treatment parameters influence outcomes. This could lead to improved radiation therapy techniques that minimize side effects for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with specific types of cancer, such as cutaneous lymphoma or bone metastases, who are undergoing radiation therapy.
Not a fit: Patients with conditions that do not involve radiation therapy or those who are not candidates for FLASH radiation treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer radiation therapy options that reduce damage to healthy tissues while effectively treating cancer.
How similar studies have performed: While FLASH radiation therapy is a relatively new approach, preliminary studies in animal models have shown promising results, indicating potential for success in human applications.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Schuemann, Jan Patrick Oscar — Massachusetts General Hospital
- Study coordinator: Schuemann, Jan Patrick Oscar
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.